-
Something wrong with this record ?
Screening of the chemoprotective effect of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate against 2-chloroethyl ethyl sulfide
Petr Jost, Jaroslav Pejchal, Tomas Kucera, Lubica Muckova, Rudolf Stetina
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't
- MeSH
- Antidotes MeSH
- Chemical Warfare Agents toxicity MeSH
- Chemoprevention MeSH
- Comet Assay MeSH
- Cells, Cultured drug effects MeSH
- Mesna analogs & derivatives therapeutic use MeSH
- DNA Damage drug effects MeSH
- Mutagenicity Tests methods MeSH
- Mustard Gas * analogs & derivatives toxicity MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
2-chloroethyl ethyl sulfide (CEES) is a vesicant agent, commonly referred to half mustard due to its ability to form monofunctional adducts with DNA. In this study, we evaluated the chemoprotective potential of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate (MESNA) against CEES-induced geno- and cytotoxicity in human lung cell line A-549. MESNA, L-glutathione (GSH), thiourea, sodium thiosulfate, hexamethylenetetramine, 4-acetamidophenol, asoxime dichloride (HI-6), N-acetyl-L-cysteine (NAC), sodium pyruvate, myo-inositol, 3-aminobenzamide (3-AB), nicotinamide, and Nω-nitro-L-arginine methyl ester hydrochloride and combinations of these compounds with MESNA were applied 30 min before CEES. DNA alkylation was measured using modified comet assay 1 and 24 h after the exposure. Cell viability was determined using MTT assay at 24 and 72 h. The mono-therapeutical approach identified MESNA and GSH to provide significant chemoprotection. NAC and 3-AB supported DNA damage repair, while cell viability remained unaffected. Mixtures of GSH or NAC with MESNA showed protective synergism against DNA damage. Other compounds or their combinations with MESNA failed due to the potentiation of CEES-induced cytotoxicity. The chemoprotection against CEES remains limited; however, the combination of substances can provide protective synergy and may represent a promising strategy in the treatment of accidental exposure to monoalkylating agents.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19032535
- 003
- CZ-PrNML
- 005
- 20200420120708.0
- 007
- ta
- 008
- 190923s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2019.009 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Jošt, Petr $7 xx0225106 $u University of Defense, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- 245 10
- $a Screening of the chemoprotective effect of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate against 2-chloroethyl ethyl sulfide / $c Petr Jost, Jaroslav Pejchal, Tomas Kucera, Lubica Muckova, Rudolf Stetina
- 504 __
- $a Literatura
- 520 9_
- $a 2-chloroethyl ethyl sulfide (CEES) is a vesicant agent, commonly referred to half mustard due to its ability to form monofunctional adducts with DNA. In this study, we evaluated the chemoprotective potential of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate (MESNA) against CEES-induced geno- and cytotoxicity in human lung cell line A-549. MESNA, L-glutathione (GSH), thiourea, sodium thiosulfate, hexamethylenetetramine, 4-acetamidophenol, asoxime dichloride (HI-6), N-acetyl-L-cysteine (NAC), sodium pyruvate, myo-inositol, 3-aminobenzamide (3-AB), nicotinamide, and Nω-nitro-L-arginine methyl ester hydrochloride and combinations of these compounds with MESNA were applied 30 min before CEES. DNA alkylation was measured using modified comet assay 1 and 24 h after the exposure. Cell viability was determined using MTT assay at 24 and 72 h. The mono-therapeutical approach identified MESNA and GSH to provide significant chemoprotection. NAC and 3-AB supported DNA damage repair, while cell viability remained unaffected. Mixtures of GSH or NAC with MESNA showed protective synergism against DNA damage. Other compounds or their combinations with MESNA failed due to the potentiation of CEES-induced cytotoxicity. The chemoprotection against CEES remains limited; however, the combination of substances can provide protective synergy and may represent a promising strategy in the treatment of accidental exposure to monoalkylating agents.
- 650 12
- $a yperit $x analogy a deriváty $x toxicita $7 D009151
- 650 _2
- $a antidota $7 D000931
- 650 _2
- $a chemické bojové látky $x toxicita $7 D002619
- 650 _2
- $a chemoprofylaxe $7 D018890
- 650 _2
- $a mesna $x analogy a deriváty $x terapeutické užití $7 D015080
- 650 _2
- $a poškození DNA $x účinky léků $7 D004249
- 650 _2
- $a kultivované buňky $x účinky léků $7 D002478
- 650 _2
- $a kometový test $7 D020552
- 650 _2
- $a testy genotoxicity $x metody $7 D009152
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pejchal, Jaroslav $7 xx0102560 $u University of Defense, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- 700 1_
- $a Kučera, Tomáš. $d 1991- $7 xx0240426 $u University of Defense, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- 700 1_
- $a Múčková, Ľubica $7 xx0233697 $u University of Defense, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- 700 1_
- $a Štětina, Rudolf, $d 1947- $7 xx0060270 $u University of Defense, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 17, č. 2 (2019), s. 136-145 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2019/02/06.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20190923112237 $b ABA008
- 991 __
- $a 20200420120704 $b ABA008
- 999 __
- $a ok $b bmc $g 1446016 $s 1071040
- BAS __
- $a 3
- BMC __
- $a 2019 $b 17 $c 2 $d 136-145 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK125 $d 20200420 $a NLK 2019-36/dk